Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
12.05 EUR | +0.84% | -1.63% | -5.49% |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.49% | 356M | |
+28.30% | 676B | |
+24.11% | 554B | |
-7.85% | 349B | |
+14.40% | 318B | |
+6.61% | 291B | |
+2.91% | 210B | |
-0.48% | 204B | |
-9.98% | 194B | |
-11.64% | 144B |
- Stock Market
- Equities
- HYL Stock
- News Hyloris Pharmaceuticals SA
- Hyloris Pharmaceuticals Receives US FDA Request For Additional Information On Maxigesic